Precision Treatment to Promote Smoking Cessation and Survival in Oncology Patients

Principal Investigator: Dr. Ted Thomas 
Study Coordinator: Carla Probst

The overarching purpose of this study is to test clinician- and patient-level effects of a precision treatment intervention (PT) in comparison to usual care (UC) on tobacco treatment in hematology/ oncology clinics. The study team will enroll approximately 12 clinicians and approximately 96 screen-eligible patients from a diverse hematology/oncology setting to be enrolled in this study. Participating clinicians will be randomly assigned to one of 2 groups: Usual Care (UC) or Precision Treatment (PT).

To learn more about PROMISE  and how you can join contact our research office at (314) 289-7690

The study is funded by our Foundation a subaward with DOD and Washington University in St. Louis